![Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome | Nature Medicine Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-019-0343-4/MediaObjects/41591_2019_343_Fig1_HTML.png)
Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome | Nature Medicine
![Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41587-020-0561-9/MediaObjects/41587_2020_561_Fig1_HTML.png)
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology
![Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy | Cancer Gene Therapy Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy | Cancer Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41417-023-00597-z/MediaObjects/41417_2023_597_Fig1_HTML.png)
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy | Cancer Gene Therapy
![CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41698-019-0080-7/MediaObjects/41698_2019_80_Fig1_HTML.png)
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
![The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00283-8/MediaObjects/41392_2020_283_Fig1_HTML.png)
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
![Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy | Nature Nanotechnology Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy | Nature Nanotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41565-022-01122-3/MediaObjects/41565_2022_1122_Fig1_HTML.png)
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy | Nature Nanotechnology
![The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41580-019-0131-5/MediaObjects/41580_2019_131_Fig1_HTML.png)
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
![Nature-inspired CRISPR enzymes for expansive genome editing | MIT News | Massachusetts Institute of Technology Nature-inspired CRISPR enzymes for expansive genome editing | MIT News | Massachusetts Institute of Technology](https://news.mit.edu/sites/default/files/images/202005/crispr-enzyme-dna_0.jpg)
Nature-inspired CRISPR enzymes for expansive genome editing | MIT News | Massachusetts Institute of Technology
![In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41590-022-01315-x/MediaObjects/41590_2022_1315_Fig1_HTML.png)
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology
![Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41587-023-01756-1/MediaObjects/41587_2023_1756_Fig1_HTML.png)
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology
Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants | ACS Agricultural Science & Technology
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
![The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41580-019-0131-5/MediaObjects/41580_2019_131_Fig3_HTML.png)